10006351 J Clin Psychiatry / Document Archive

Psychiatrist.com Home    Keyword Search

Close [X]

Search Our Sites

Enter search terms below (keywords, titles, authors, or subjects). Then select a category to search and press the Search button. All words are assumed to be required. To search for an exact phrase, put it in quotes. To exclude a term, precede it with a minus sign (-).

Keyword search:

Choose a category:

Choosing the appropriate category will greatly improve your chances of finding the best match.

All files at our sites: J Clin Psychiatry, Primary Care Companion, CME Institute, and MedFair

Search materials from our journals:

Abstracts from The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements

PDFs of the full text of The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements (Net Society Platinum [paid subscribers])

PDFs of the full text of The Primary Care Companion to The Journal of Clinical Psychiatry, 1999–present

Search CME offerings:

CME Institute, including CME from journals , supplements, and Web activities for instant CME credit (Net Society Gold [registered users]); also includes information about our CME program

CME activities from regular issues of The Journal of Clinical Psychiatry (Net Society Gold [registered users])

CME Supplements from The Journal of Clinical Psychiatry (Net Society Gold [registered users])

 

The article you requested is

Treatment of Dementia With Behavioral Disturbance Using Divalproex or a Combination of Divalproex and a Neuroleptic

J Clin Psychiatry 1997;58:351-354
Copyright 1997 Physicians Postgraduate Press, Inc.

To view this item, select one of the options below.

  1. NONSUBSCRIBERS
    1. Purchase this PDF for $30
      If you are not a paid subscriber, you may purchase the PDF.
      (You'll need the free Adobe Acrobat Reader.)
    2. Subscribe
      Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($129) or print + online ($166 individual).
    3. Celebrate JCP's 75th Anniversary with a special online-only subscription price of $75.
  2. PAID SUBSCRIBERS
    1. Activate
      If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
    2. Sign in
      As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
  1. Did you forget your password?

Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email

| 67.202.4.225

Background: Neuroleptics have been used extensively to treat noncognitive behavioral disturbances in dementia, although their efficacy is only moderate and side effects are prominent. This study aims to determine the efficacy and tolerability of the non-neuroleptic divalproex sodium in patients with dementia and behavioral problems.

Method: Charts of consecutive inpatients with dementia and behavioral problems according to DSM-IV were retrospectively reviewed. Patients treated with divalproex were analyzed for dosage, duration of divalproex treatment, levels, efficacy, side effects, and concurrent medications. Target behavioral symptoms were identified, and change was rated using a Clinical Global Impressions (CGI)-Severity of Illness scale. Patients who were much or very much improved were considered to be responders.

Results: Twenty-five patients (15 men and 10 women) with a mean±SD age of 77±7 years were identified. Fourteen (56%) of the 25 patients met our criteria for response after the addition of divalproex. Divalproex given alone was effective in 7 of 15 patients. Divalproex was added to an ongoing neuroleptic in 10 patients, and 7 patients responded. Patients received a mean final divalproex dose of 1650 mg/day with a mean blood level of 64 mg/mL. Divalproex was well tolerated in this population except for reversible sedation in 8 patients and transient worsening gait and confusion in 1 subject.

Conclusion: Divalproex appeared to be as effective as previously reported rates for neuroleptics in the treatment of behavioral disturbances in dementia. The combination of divalproex and a neuroleptic was effective in patients who had failed either agent administered independently.